Drag a card by its title · ⚙ to size, swap or remove

The company

Recursion Pharmaceuticals, Inc.

RXRX · Nasdaq

Health CareBiotechnologyJust started movingAISynthetic Biology / TechBioSynthetic Biology / TechBio

RXRX stood above a rising 150-day average in 2 of the last 52 weekly readings, including each of the last 2 weeks. It is 1.7% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Just started moving
Weeks in an uptrend: 2 in a row
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $13.2M
Officials’ trades on record: 0
Institutions holding: 327 (+9)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 2 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months36

Buyers · sellers0 · 6

Who	Did	Shares	Traded
Robert HershbergDirector	sold	25,000at $5.00	6 Oct 2026filed 7 Oct 2026
Blake BorgesonDirector	sold	50,000at $4.84	6 Oct 2026filed 7 Oct 2026
Najat KhanCEO and President	sold	22,408at $3.52	8 Sep 2026filed 10 Sep 2026
Blake BorgesonDirector	sold	30,000at $3.34	1 Sep 2026filed 2 Sep 2026
Blake BorgesonDirector	sold	30,000at $3.25	4 Aug 2026filed 6 Aug 2026
Blake BorgesonDirector	sold	40,000at $3.96	7 Jul 2026filed 9 Jul 2026
Namandje BumpusDirector	sold	3,963at $3.18	18 Jun 2026filed 22 Jun 2026
Christopher GibsonDirector	sold	40,000at $3.62	5 Jun 2026filed 5 Jun 2026
Najat KhanCEO and President	sold	23,588at $3.58	5 Jun 2026filed 5 Jun 2026
Namandje BumpusDirector	sold	4,386at $3.54	3 Jun 2026filed 4 Jun 2026
Blake BorgesonDirector	sold	30,000at $3.68	2 Jun 2026filed 4 Jun 2026
Christopher GibsonDirector	sold	40,000at $3.08	22 May 2026filed 27 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders327+9 on the quarter

New · exited55 · 45

Reported value$1.3B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.added · filed 7 Aug 2026	50,304,691$184.6M	+7,112,385+16.5%
ARK Investment Management LLCadded · filed 14 Aug 2026	41,337,632$151.7M	+1,124,863+2.8%
STATE STREET CORPadded · filed 7 Aug 2026	34,706,130$127.4M	+6,215,492+21.8%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026	31,131,599$114.3M	+8,372,499+36.8%
BAILLIE GIFFORD & COreduced · filed 6 Aug 2026	23,487,907$86.2M	-187,500−0.8%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	22,765,940$83.6M	+521,553+2.3%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	13,819,135$50.7M	+1,544,051+12.6%
SOFTBANK GROUP CORP.unchanged · filed 14 Aug 2026	13,636,515$50.0M	00.0%
MIC Capital Management UK LLPadded · filed 10 Aug 2026	9,644,033$35.4M	+10.0%
UBS Group AGadded · filed 13 Aug 2026	8,947,102$32.8M	+3,845,865+75.4%